A Shift in Sentiment for Canopy Growth Shares

As Canopy Growth approaches the close of its 2026 fiscal year, a wave of unexpected analyst support is providing a fresh perspective. While the stock price remains below key technical levels, newly issued buy ratings and the recent completion of the MTL Cannabis acquisition are altering the market’s view.

Regulatory Horizon Holds Key to Future Valuation

A pivotal element for the company’s future valuation continues to be the U.S. regulatory landscape. In mid-March, U.S. lawmakers reintroduced the CLIMB Act into the House of Representatives. This proposed legislation aims to facilitate access to U.S. stock exchanges and standard financial services for cannabis companies. The stakes are high for Canopy Growth. Its “Canopy USA” legal structure is specifically designed to assume full control of profitable U.S. assets and consolidate their revenue immediately upon a change in federal law.

Analyst Upgrades Follow Strategic Acquisition

Market experts at Canaccord Genuity have initiated coverage of the stock with a buy recommendation and a price target of 2 Canadian dollars. Notably, the investment bank previously served as the exclusive financial advisor to Canopy Growth during its acquisition of rival MTL Cannabis. This move bolsters the bullish camp within an otherwise divided analyst community. Back in mid-March, ATB Cormark Capital Markets also upgraded the stock following the closure of the MTL deal. The current analyst consensus shows two buy recommendations against three hold and two sell ratings.

Should investors sell immediately? Or is it worth buying Canopy Growth?

Debt Management and Mixed Quarterly Results

The company’s fiscal year concludes on March 31, which also coincides with a scheduled debt repayment of $15 million US. Given liquid assets of $371 million US at the turn of the year, this payment does not pose an operational challenge. Furthermore, management recently extended all outstanding maturities until at least January 2031, significantly alleviating near-term financial pressure.

The latest fundamental data, however, presents a mixed picture. Revenue for the most recent quarter came in at just over $90 million US, comfortably surpassing Wall Street’s expectations. Conversely, the loss per share of $0.10 US was greater than market forecasts, even though the net loss was nearly halved compared to the previous year.

Performance and Upcoming Catalyst

Despite the positive analyst commentary, the share price continues to trade weakly and remains well below its 200-day moving average of $1.23 US. The tangible effects of the MTL acquisition and the $10 million US in synergies targeted by management must now be demonstrated with hard results. Investors await the next significant data point on May 29, 2026, when the company is scheduled to release the first comprehensive quarterly report for the newly structured group.